Advertisement

Lymphokines and the Lymphoendothelial System : An Illustration of Immunoregulatory Integration

  • D. C. Dumonde
  • Anne S. Hamblin
  • Eva Kasp-Grochowska
  • Melanie S. Pulley
  • R. A. Wolstencroft

Abstract

The possibility that non-antibody products of lymphocyte activation might be involved in the expression and regulation of lymphocyte function arose indirectly from consideration of the role of lymphocytes and macrophages in experimental delayed hypersensitivity (Dumonde, 1967; Dumonde et al., 1968). Analysis of experimental cell-mediated immune phenomena had pointed to the role of cellular interactions between a few specifically sensitized lymphocytes and the majority of other host cells participating in these responses (see Turk, 1967). These features were consistent with the concept that special ‘mediators’ of cellular immunity could well facilitate such interactions; and that this would bring the cellular immune system into line with other biological systems in which differentiated cell products (for example endocrine and neurotransmitter substances) were known to mediate complex physiological events.

Keywords

Acute Phase Protein Lymphocyte Activation Advanced Cancer Patient Lymphoid Cell Line Ciba Foundation Symposium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adelman, N.E., Hammond, E., Cohen, S., and Dvorak, D., 1979, Lymphokines as inflammatory mediators, in: “Biology of Lymphokines”, S. Cohen, E. Pick and J.J. Oppenheim, eds., Accademic Press, New York, p. 13.Google Scholar
  2. Anderson, A.O., and Anderson, N.D., 1976, Lymphocyte emigration from high endothelial venules in rat lymph nodes, Immunology, 31:731.PubMedGoogle Scholar
  3. Atkins, E., and Francis, L., 1978, Pathogenesis of fever in delayed hypersensitivity: factors influencing release of pyrogen-inducing lymphokines, Infect. Immun., 21:806.PubMedGoogle Scholar
  4. Besedovsky H., and Sorkin, E., 1977, Network of immune-neuroendocrine interactions, Clin. Exp. Immunol., 27:1.PubMedGoogle Scholar
  5. Besedovsky, H.O., Del Rey, A., and Sorkin, E., 1981, Lymphokine-containing supernatants from Con A-stimulated cells increase corticosterone blood levels, J. Immunol., 126:385.PubMedGoogle Scholar
  6. Blackwell, G.J., Carnuccio, R., di Rosa, M., Flower, R.J., Parente, L., and Persico, P., 1980, Macrocort in: a polypeptide causing the anti-phospholipase effect of glucocorticoids, Nature, 287:147.Google Scholar
  7. Bressler, J.P., Thurman, G.B., Krzych, U., Goldstein, A.L., Trivers G., and Strausser, H.R., 1980, Lymphokines secreted from sodium periodate-treated lymphocytes, Cell. Immunol., 54:274.PubMedCrossRefGoogle Scholar
  8. Burger, D.R., Ford, D., Vetto, R.M., Hamblin, A., Goldstein, A., Hubbard, M., and Dumonde, D.C., 1981, Endothelial cell presentation of antigen to human T cells, Human Immunology, 3:209.PubMedCrossRefGoogle Scholar
  9. Butcher, E.C., and Weissman, I.L., 1980, Cellular, genetic and evolutionary aspects of lymphocyte interactions with high-endothelial venules, in: “Blood cells and vessel walls: functional interactions”, Ciba Foundation Symposium 71, Excerpta Medica, New York, p.265.Google Scholar
  10. Butcher, E., Scollay, R., and Weissman, E., 1979, Evidence of continous evolutionary change in structures mediating adherence of lymphocytes to specialized venules, Nature, 280:496.PubMedCrossRefGoogle Scholar
  11. Cohen, S., 1980, Lymphokines in delayed hypersensitivity, in: “Immunology 80” M. Fougereau and J. Dausset, eds., Academic Press, New York, p.860Google Scholar
  12. Cohen, S., Pick, E., Oppenheim, J.J., 1979, “Biology of the Lymphokines”, Academic Press, New York.Google Scholar
  13. Cox, J.H., 1981, Systemic factors influencing lymphocyte recirculation, PhD thesis, University of Manchester.Google Scholar
  14. Cox, J.H. and Ford, W.L., 1982, The migration of lymphocytes across specialised vascular endothelium. IV. Prednisolone acts at several points on the recirculation pathways of lymphocytes, Cell. Immunol., in press.Google Scholar
  15. Curtis, A.S.G., 1978, Cell-cell recognition: positioning and patterning systems, Symp. Soc. Exp. Biol., 32:51.PubMedGoogle Scholar
  16. De Sousa, M., 1981, “Lymphocyte circulation: experimental and clinical aspects” John Wiley, New York.Google Scholar
  17. De Weck, A.L., Kristensen, F., and Landy, M., 1980, “Biochemical Characterization of Lymphokines”, Academic Press, New York.Google Scholar
  18. Dinarello, C.A., Renfer, L., and Wolff, S.M., 1977, The production of antibody against human leucocytic pyrogen, J. Clin. Invest., 60:465.PubMedCrossRefGoogle Scholar
  19. Distelhorst, C.W., and Benutto, B., 1981, Glucocorticoid receptor content of T lymphocytes: evidence for heterogeneity, J. Immunol., 126:1630.PubMedGoogle Scholar
  20. Dumonde, D.C., 1967, The role of the macrophage in delayed hypersensitivity, Brit, ed. Bull., 23:9.Google Scholar
  21. Duonde, D.C., 1970, “Lymphokines”: Mediators and regulators of cellular immune responses, Ann. Immunol., II, 3:129.Google Scholar
  22. Dumonde, D.C., 1978, The rheumatological signifance of lymphokines in: “Recognition of anti-rheumatic drugs”, D.C. Dumonde and M.K. Jasani, eds., MTP Press Ltd., Lancaster, p. 167.Google Scholar
  23. Dumonde, D.C., and Maini, R.N., 1971, The clinical significance of mediators of cellular immunity, Clin. Allergy, 1:123.PubMedCrossRefGoogle Scholar
  24. Dumonde, D.C., Howson, W.T. and Wolstencroft, R.A., 1968, The role of macrophages and lymphocytes in reactions of delayed hypersensitivity. in: “Mechanisms of inflammation induced by immune reaction”, Vth Internat. Symp. Immunopathol., 1967, P.A. Miescher and P. Grabar eds., p. 263. Schwabe, Basel, 278.Google Scholar
  25. Dumonde, D.C., Wolstencroft, R.A., Panayi, G.S., Matthew, M., Morley, J., and Howson, W.T., 1969, “Lymphokines”: Non-antibody mediators of cellular immunity generated by lymphocyte activation, Nature, 224:38.PubMedCrossRefGoogle Scholar
  26. Dumonde, D.C., Kelly, R.H., and Wolstencroft, R.A., 1973, Molecular pharmacology of cell-mediated immunity, in: “Microenvironmental aspects of Immunity”, B.D. Jankovic and K. Isakovic, eds., p. Plenum Press, New York, p.705Google Scholar
  27. Dumonde, D.C., Jose, P.J., Page, D.A., and Williams, T.J., 1977, Production of prostaglandins by porcine endothelial cells in culture, Brit. J. Pharmacol, 61:504.Google Scholar
  28. Dumonde, D.C., Pulley, M.S., O’Connel, D., Soughcott, B.M., Robinson M.R.G., Paradinas, F.J., Rigby, C.C., den Hollander, F.C., Schuurs, A., and de Bruin, R.W., 1980, Local and systemic administration of lymphokine in patients with advanced cancer, Int. J. Immunopharmacol., 2(3):190.CrossRefGoogle Scholar
  29. Dumonde, D.C., Pulley, M.S., Paradinas, F.J., Southcott, B.M., O’Connell, D., Robinson, M.R.G., and den Hollander, F., 1981, A histological study of intradermal and intralesional injection of human lymphoid cell line lymphokine (LCL-LK) in patients with advanced cancer, in: “Proc. 3rd Internat. Symp. on Human Lymphokines, A. Khan and N.O. Hill, eds., New York, Academic Press, in press.Google Scholar
  30. Ford, W.L., 1975, Lymphocyte migration and immune responses, Prog. Allergy, 19:1.PubMedGoogle Scholar
  31. Ford, W.L., Smith, M.E., and Andrews, P., 1978, Possible clues to the mechanism underlying the selective migration of lymphocytes from the blood, in: “Cell-cell recognition”, A.S.G. Curtis, ed., Symp. Soc. Exp. Biol., 32:359.Google Scholar
  32. Gillis, S., Crabtree, G.R. and Smith, K.A., 1979, Glucocorticoid-induced inhibition of T-cell growth factor production. II. The effect on the “in vitro” generation of cytolytic T cells., J. Immunol., 123:1631.Google Scholar
  33. Goldstein, A.L., and Chirigos, M.A., 1981, “Lymphokines and thymic factors and their potential utilization in cancer therapeutics”. Raven Press, New York.Google Scholar
  34. Gowans, J.L. and Steer, H.W., 1980, The function and pathways of lymphocyte recirculation, in: “Blood cells and vessel walls: functional interactions”, Ciba Foundation Symposium 71, Excerpta Medica, New York, p.113.Google Scholar
  35. Hadden, J.W., and Stewart, W.E., 1981, “The Lymphokines: Biochemistry and biological activity.” Humana Press, Clifton, New Jersey.Google Scholar
  36. Hirschberg, H., Berg, O.J. and Thorsby, E., 1980, Antigen-presenting properties of human vascular endothelial cells, J. Exp. Med., 152:180.Google Scholar
  37. Hopkins, J., McConnell, I. and Pearson, J.D., 1981, Lymphocyte traffic through antigen-stimulated lymph nodes. II. Role of prostaglandin E2 as a mediator of cell shut-down, Immunology, 42:225.PubMedGoogle Scholar
  38. Jose, P.J., Page, D.A., Wolstenholme, B.E., Williams, T.J., and Dumonde, D.C., 1981, Bradykinin-stimulated prostaglandin E2 production by endothelial cells and its modulation by antiinflammatory compounds, Inflammation, 5:375.CrossRefGoogle Scholar
  39. Kasp-Grochowska, E., Page, D.A., Povey, J., Dumonde, D.C., Jose, P., and Williams, T.J., 1982a, Modulation of lymphocyte transformation by soluble products of cultured endothelial cells, submitted for publicationGoogle Scholar
  40. Kasp-Grochowska, E., Anderson, R., and Dumonde, D.C., 1982b, Lymphocyte-endothelial interactions “in vitro”: enhanced association of periodate-activated lymphocytes with confluent endothelial cell monolayers, submitted for publication.Google Scholar
  41. Kelly, R.H. and Wolstencroft, R.A., 1974, Germinal centre proliferation in response to mitogenic lymphokines, Clin. Exp. Immunol., 18:321.PubMedGoogle Scholar
  42. Kelly, R.H., Wolstencroft, R.A., Dumonde, D.C., and Balfour, B.M., 1972, Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node activation architecture and evidence for peripheral release of LAP following antigenic stimulation, Clin. Exp. Immunol., 10:49.PubMedGoogle Scholar
  43. Kelly, R.H., Harvey, V.S., Sadler, T.E., and Dumonde, D.C., 1975, Accelerated cytodifferentiation of antibody-secreting cells in guinea-pig lymph nodes stimulated by sheep erythrocytes and lymphokines, Clin. Exp. Immunol., 20:141.Google Scholar
  44. Manning, M.J. and Turner, R.J., 1976, “Comparative Immunobiology” Blackie, London.Google Scholar
  45. Moore, M.A.S., 1981, Macrophage regulatory networks, in: “The Lymphokines: Biochemistry and biological activity”, J.W. Hadden and W.E. Stewart, eds., Humana Press, p.305. Clifton, New Jersey.Google Scholar
  46. Mortensen, R.F., Osmand, A.P., and Gewurz, H., 1975, Effects of C-reactive protein on the lymphoid system: I. Binding to thymus-dependent lymphocytes and alteration of their functions, J. Exp. Med., 141:821.PubMedGoogle Scholar
  47. Murphy, P.A., Simon, P.L. and Willoughby, W.F., 1980, Endogeneous pyrogens made by rabbit peritoneal exudate cells are identical with lymphocyte-activating factors made by rabbit alveolar macrophages, J. Immunol., 124:2498PubMedGoogle Scholar
  48. Neta, R., and Salvin, S., 1981, Production of lymphokines “in vivo”, Lymphokines, 2:295.Google Scholar
  49. Paetkau, V., 1981, Lymphokines on the move, Nature, 294:689.PubMedCrossRefGoogle Scholar
  50. Pepys, M.B., 1981, C-reactive protein fifty years on, Lancet, (i):653.CrossRefGoogle Scholar
  51. Pick, E., ed., 1980, “Lymphokine Reports: a forum for non-antibody lymphocyte products”, Vol. 1, Academic Press, New York.Google Scholar
  52. Polverini, P.J., Cotran, R.S., and Sholley, M.M., 1977, Endothelial proliferation in the delayed hypersensitivity reaction: an autoradiographic study, J. Immunol., 118:529.PubMedGoogle Scholar
  53. Pulley, M., Dumonde, D.C., Carter, G., Muller, B., Fleck, A., Southcott, B.M., and den Hollander F., 1981, Hormonal, haemato-logical and acute phase protein responses of advanced cancer patients to the intravenous injection of lymphoid cell lymphokine, in: “International Symposium on Human Lymphokines”, A. Khan and N.O. Hill, eds., Academic Press, New York, in press.Google Scholar
  54. Rao, K.M.K., and Schwarts, S.A., 1980, Zinc modulates mitogenic responses of human lymphocytes by affecting structures influenced by cytochalasin B, Clin. Immunol. Immunopathol., 16:463.PubMedCrossRefGoogle Scholar
  55. Rather, L.J., 1972, “Addison and the White Corpuscles: an aspect of ninetenth century biology”, Wellcome Institute of the History of Medicine, London.Google Scholar
  56. Sidley, Y.A., and Auerbach, R., 1975, Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-v-host reaction, J. Exp. Med., 141:1084.CrossRefGoogle Scholar
  57. Smith, K.A., Crabtree, G.R., Kennedy, S.J., and Munck, A.U., 1977, Glucocorticoid receptors and glucocorticoid sensitivity of mitogen-stimulated and unstimulated human lymphocytes, Nature, 267:523.PubMedCrossRefGoogle Scholar
  58. Smith, K.A., Lachman, L.B., Oppenheim, J.J. and Favata, M.F., 1980, The functional relationships of the interleukins, J. Exp. Med., 151:1551.PubMedCrossRefGoogle Scholar
  59. Stamper, H.B., and Woodruff, J.J., 1976, Lymphocyte homing into lymph nodes: “in vitro” demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules, J. Exp. Med., 144:828.PubMedCrossRefGoogle Scholar
  60. Thorgeirsson, G. and Robertson, A.L., 1978, The Vascular Endothelium — Pathobiologic significance, Amer. J. Pathol., 93:803.Google Scholar
  61. Thomson, S.P., McMahon, L.J., and Nugent, CA., 1980, Endogeneous Cortisol: a regulator of the number of lymphocytes in peripheral blood, Clin. Immunol. Immunopathol., 17:506.PubMedCrossRefGoogle Scholar
  62. Trevella, W., and Morris, B., 1980, Reassortment of cell populations within the lymphoid apparatus of the sheep, in: “Blood vessels and vessel walls: functional interactions”, Ciba Foundation Symposium, 71:127–139.Google Scholar
  63. Turk, J. L., 1967, “Delayed Hypersensitivity”, North-Holland, Amsterdam.Google Scholar
  64. Waksman, B. H., 1980, Lymphokine research: a historical review, Lymphokine Reports, 1:1–5.Google Scholar
  65. Willmer, E. N., 1960, “Cytology and Evolution”, Academic Press, New York.Google Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • D. C. Dumonde
    • 1
  • Anne S. Hamblin
    • 1
  • Eva Kasp-Grochowska
    • 1
  • Melanie S. Pulley
    • 1
  • R. A. Wolstencroft
    • 1
  1. 1.Department of ImmunologySt Thomas’s Hospital and Medical SchoolLondonUK

Personalised recommendations